Susquehanna International Group’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,578
Closed -$356K 13948
2025
Q4
$356K Buy
+12,578
New +$355K ﹤0.01% 9550
2024
Q3
Sell
-9,176
Closed -$214K 12865
2024
Q2
$214K Buy
+9,176
New +$214K ﹤0.01% 10215
2023
Q3
Sell
-21,924
Closed -$458K 12810
2023
Q2
$458K Sell
21,924
-4,889
-18% -$98.3K ﹤0.01% 8528
2023
Q1
$532K Buy
26,813
+6,752
+34% +$135K ﹤0.01% 8419
2022
Q4
$392K Buy
20,061
+1,340
+7% +$26.4K ﹤0.01% 8435
2022
Q3
$335K Buy
18,721
+1,550
+9% +$30.4K ﹤0.01% 9502
2022
Q2
$326K Buy
+17,171
New +$350K ﹤0.01% 9362

Other funds holding REVS

Susquehanna International Group's REVS Position: Q1 2026 in Review

Susquehanna International Group sold out of Columbia Research Enhanced Value ETF (REVS) in Q1 2026, closing a stake of 12,578 shares — an estimated $356K sold.

Susquehanna International Group first reported a position in REVS in Q2 2022 and held it in 7 quarters. The position peaked at $532K in Q1 2023. 37 funds tracked by Wall St. Rank hold REVS as of Q1 2026.

  • Susquehanna International Group reported no remaining Columbia Research Enhanced Value ETF position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 12,578 Columbia Research Enhanced Value ETF shares in Q1 2026, an estimated $356K.
  • Susquehanna International Group first reported a position in Columbia Research Enhanced Value ETF in Q2 2022 and held it in 7 quarters.
  • Susquehanna International Group's Columbia Research Enhanced Value ETF position peaked at $532K in Q1 2023.
  • 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.